This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Terhes, G.
Right arrow Articles by Nagy, E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Terhes, G.
Right arrow Articles by Nagy, E.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, November 2009, p. 3478-3481, Vol. 47, No. 11
0095-1137/09/$08.00+0     doi:10.1128/JCM.01133-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Comparison of a Rapid Molecular Method, the BD GeneOhm Cdiff Assay, to the Most Frequently Used Laboratory Tests for Detection of Toxin-Producing Clostridium difficile in Diarrheal Feces {triangledown}

Gabriella Terhes,1* Edit Urbán,1 József Sóki,1 Eniko Nacsa,2 and Elisabeth Nagy1

Institute of Clinical Microbiology, Albert Szent-Györgyi Medical and Pharmaceutical Center, H-6725 Szeged, Hungary,1 Department of Infectious Diseases, Albert Szent-Györgyi Medical and Pharmaceutical Center, H-6725 Szeged, Hungary2

Received 10 June 2009/ Returned for modification 2 August 2009/ Accepted 18 September 2009

Six hundred diarrheal stool specimens were collected from inpatients and outpatients at local university hospitals for the detection of toxigenic Clostridium difficile using three parallel methods, the BD GeneOhm Cdiff assay, the tissue culture cytotoxicity assay, and a commercially available enzyme-linked fluorescence immunoassay (ELFA) (Vidas C. difficile toxin A and B assay; bioMérieux). Toxigenic C. difficile culture was also performed to further clarify discordant results. During a 3-month study period, 58 (9.7%) of the 600 diarrheal samples examined were positive by the BD GeneOhm Cdiff assay, while the Vidas C. difficile toxin A and B assay and the cytotoxicity assay performed directly on stool samples gave 4.7% and 6.3% positivity rates, respectively. In the case of four samples, BD GeneOhm Cdiff assay results were not evaluable at first because of the presence of PCR inhibitors, but upon repeat testing from the frozen lysates, all of these samples proved to be negative. After resolution with toxigenic culture, the cytotoxicity assay proved to be positive in 55 samples (9.2%), while the ELFA was positive in 37 samples (6.2%). Results of culture and repeated cytotoxicity assays emphasized the importance of the culture method, because the use of ELFA or enzyme immunoassay without a culture method may lead to a substantial portion of toxigenic C. difficile strains being missed.

* Corresponding author. Mailing address: Institute of Clinical Microbiology, Albert Szent-Györgyi Medical and Pharmaceutical Center, H-6725 Szeged, Semmelweis u 6., Hungary. Phone and fax: 36 62 545712. E-mail: terhesga{at}freemail.hu

{triangledown} Published ahead of print on 30 September 2009.

Journal of Clinical Microbiology, November 2009, p. 3478-3481, Vol. 47, No. 11
0095-1137/09/$08.00+0     doi:10.1128/JCM.01133-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»